Please login to the form below

Not currently logged in
Email:
Password:

Chiesi Global Rare Diseases

This page shows the latest Chiesi Global Rare Diseases news and features for those working in and with pharma, biotech and healthcare.

FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox

FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox

Italy’s Chiesi Global Rare Diseases has gained approval from the US Food and Drug Administration (FDA) for the expanded use of its sickle cell disease (SCD) treatment Ferriprox. ... chelation therapy, including those with known kidney issues who have

Latest news

  • Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease

    Protalix Biotherapeutics and Chiesi Global Rare Diseases’s monthly treatment PRX-102 has demonstrated positive top-line results in a phase 3 trial evaluating the therapy in Fabry disease. ... On behalf of our team at Chiesi, we are grateful to the

  • Chiesi launches new rare disease R&D division Chiesi launches new rare disease R&D division

    The new business unit – Chiesi Global Rare Diseases – will be headquartered in Boston, US and will have an initial focus on research and product development in lysosomal storage disorders, rare haematology ... With the Chiesi Global Rare Diseases unit

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...